Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
395 | 16247 | 41.6 | 75% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1579 | 2503 | CYP2D6//DEBRISOQUINE//CYP2C19 |
2213 | 2246 | CYP2C12//ONE DAY TREATMENT//S BIOCHEM |
4336 | 1729 | PREGNANE X RECEPTOR//PXR//CONSTITUTIVE ANDROSTANE RECEPTOR |
4557 | 1692 | PUTIDAREDOXIN//CYTOCHROME P450CAM//CYP106A2 |
6192 | 1453 | CYP3A//COCKTAIL//MECHANISM BASED INHIBITION |
6713 | 1378 | ANTLEY BIXLER SYNDROME//CYTOCHROME P450 OXIDOREDUCTASE//NADPH CYTOCHROME P450 REDUCTASE |
7216 | 1316 | SITE OF METABOLISM//ACTIVE SITE TOPOLOGY//COMPUTAT CHEM MOL STRUCT |
11620 | 902 | ROLLINS 5119//ANTIPYRINE PHARMACOKINETICS//CYTOCHROME P4502B1 2 |
12369 | 846 | CYP2A6//CYP2A5//CYP2A13 |
14400 | 706 | CYP1B1//CYP2S1//CYTOCHROME P4501B1 |
21474 | 359 | MARIE LOWE COMPARAT ONCOL//CYP2D//MARI LOWE COMPARAT ONCOL |
21966 | 342 | LIVER SLICES//PRECISION CUT TISSUE SLICES//PRECISION CUT LIVER SLICES |
23706 | 282 | GV TB//RECONSTRUCTED HUMAN SKIN MODELS//DIP FARMACOBIOL |
23988 | 274 | PHARMACOKINET BIOANAL//CYP2D19//PROPRANOLOL ENANTIOMER |
26013 | 219 | CYTOCHROME P450NOR//FUNGAL DENITRIFICATION//P450NOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CYTOCHROME P450 | Author keyword | 485 | 25% | 10% | 1681 |
2 | CYP2D6 | Author keyword | 309 | 47% | 3% | 487 |
3 | PREGNANE X RECEPTOR | Author keyword | 229 | 71% | 1% | 187 |
4 | DRUG METABOLISM AND DISPOSITION | Journal | 167 | 15% | 6% | 1054 |
5 | DEBRISOQUINE | Author keyword | 165 | 76% | 1% | 116 |
6 | CONSTITUTIVE ANDROSTANE RECEPTOR | Author keyword | 158 | 78% | 1% | 105 |
7 | PXR | Author keyword | 150 | 60% | 1% | 164 |
8 | DRUG METABOLISM | Author keyword | 147 | 27% | 3% | 460 |
9 | CYP2A6 | Author keyword | 98 | 59% | 1% | 110 |
10 | CYP3A4 | Author keyword | 96 | 28% | 2% | 293 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYTOCHROME P450 | 485 | 25% | 10% | 1681 | Search CYTOCHROME+P450 | Search CYTOCHROME+P450 |
2 | CYP2D6 | 309 | 47% | 3% | 487 | Search CYP2D6 | Search CYP2D6 |
3 | PREGNANE X RECEPTOR | 229 | 71% | 1% | 187 | Search PREGNANE+X+RECEPTOR | Search PREGNANE+X+RECEPTOR |
4 | DEBRISOQUINE | 165 | 76% | 1% | 116 | Search DEBRISOQUINE | Search DEBRISOQUINE |
5 | CONSTITUTIVE ANDROSTANE RECEPTOR | 158 | 78% | 1% | 105 | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR | Search CONSTITUTIVE+ANDROSTANE+RECEPTOR |
6 | PXR | 150 | 60% | 1% | 164 | Search PXR | Search PXR |
7 | DRUG METABOLISM | 147 | 27% | 3% | 460 | Search DRUG+METABOLISM | Search DRUG+METABOLISM |
8 | CYP2A6 | 98 | 59% | 1% | 110 | Search CYP2A6 | Search CYP2A6 |
9 | CYP3A4 | 96 | 28% | 2% | 293 | Search CYP3A4 | Search CYP3A4 |
10 | ANTLEY BIXLER SYNDROME | 89 | 84% | 0% | 48 | Search ANTLEY+BIXLER+SYNDROME | Search ANTLEY+BIXLER+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM | 430 | 31% | 7% | 1154 |
2 | PREGNANE X RECEPTOR | 424 | 42% | 5% | 781 |
3 | CONSTITUTIVE ANDROSTANE RECEPTOR | 415 | 50% | 4% | 592 |
4 | HUMAN LIVER MICROSOMES | 374 | 26% | 8% | 1227 |
5 | P 450 REDUCTASE | 332 | 65% | 2% | 314 |
6 | DEBRISOQUINE | 296 | 51% | 3% | 418 |
7 | XENOBIOTIC RECEPTOR | 266 | 81% | 1% | 158 |
8 | PXR | 239 | 71% | 1% | 194 |
9 | P450 | 236 | 43% | 3% | 417 |
10 | COUMARIN 7 HYDROXYLATION | 204 | 86% | 1% | 102 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG METABOLISM AND DISPOSITION | 167 | 15% | 6% | 1054 |
2 | XENOBIOTICA | 55 | 12% | 3% | 438 |
3 | PHARMACOGENETICS | 53 | 22% | 1% | 210 |
4 | CURRENT DRUG METABOLISM | 29 | 17% | 1% | 161 |
5 | DRUG METABOLISM REVIEWS | 17 | 13% | 1% | 122 |
6 | DRUG METABOLISM AND PHARMACOKINETICS | 16 | 15% | 1% | 97 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation | 2013 | 173 | 551 | 35% |
P450(BM3) (CYP102A1): connecting the dots | 2012 | 102 | 408 | 83% |
Cytochrome P450 monooxygenases: an update on perspectives for synthetic application | 2012 | 91 | 80 | 80% |
Cytochrome P-450 3A4: Regulation and role in drug metabolism | 1999 | 701 | 93 | 67% |
THE P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS, EARLY TRIVIAL NAMES OF ENZYMES, AND NOMENCLATURE | 1993 | 1394 | 547 | 50% |
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry | 2004 | 385 | 131 | 89% |
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity | 2005 | 387 | 49 | 80% |
Heme Enzyme Structure and Function | 2014 | 47 | 314 | 21% |
Cytochrome P450 and chemical toxicology | 2008 | 435 | 143 | 34% |
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4 | 2008 | 215 | 143 | 63% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARMACOGENET SECT | 95 | 53% | 0.8% | 125 |
2 | PHARMACOKINET BIOANAL | 42 | 59% | 0.3% | 47 |
3 | DRUG METAB | 30 | 13% | 1.3% | 208 |
4 | MOL TOXICOL | 30 | 12% | 1.5% | 242 |
5 | REPROD DEV TOXICOL | 17 | 16% | 0.6% | 95 |
6 | SECT DEV PHARMACOL EXPT THER EUT | 15 | 56% | 0.1% | 18 |
7 | CICAB CLIN | 12 | 58% | 0.1% | 14 |
8 | MOL TOXICOL GRP | 11 | 22% | 0.3% | 45 |
9 | PHARMACOGENET | 11 | 11% | 0.5% | 89 |
10 | UNIDAD HEPATOL EXPT | 10 | 26% | 0.2% | 35 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000018458 | SOLUBLE EPOXIDE HYDROLASE//EPOXYEICOSATRIENOIC ACIDS//EPOXIDE HYDROLASE |
2 | 0.0000016290 | TCDD//ARYL HYDROCARBON RECEPTOR//2 3 7 8 TETRACHLORODIBENZO P DIOXIN |
3 | 0.0000013946 | FLAVIN CONTAINING MONOOXYGENASE//FMO3//TRIMETHYLAMINURIA |
4 | 0.0000011884 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM |
5 | 0.0000011109 | VISNAGIN//AMMI VISNAGA//FURANOCHROMONES |
6 | 0.0000009693 | GSTM1//GSTT1//GLUTATHIONE S TRANSFERASE |
7 | 0.0000009493 | GRAPTOPETALUM PARAGUAYENSE E WALTHER//AGR CHEM CHIKUSA KU//AGR CHEM NUTR BIOCHEM |
8 | 0.0000008160 | BIOANALYSIS//LC NMR//DRIED BLOOD SPOT DBS |
9 | 0.0000007891 | 2 METHOXYESTRADIOL//INDOLE 3 CARBINOL//3 3 DIINDOLYLMETHANE |
10 | 0.0000007706 | HETEROCYCLIC AMINES//HETEROCYCLIC AROMATIC AMINES//ARYLAMINE N ACETYLTRANSFERASE |